Gallant
Device Cardiac Rhythm Management
PDI 05415067032010
General payments
$842,306
Research payments
$1,704,920
Through program year 2025, $842,306 in general payments and $1,704,920 in research payments were reported against Gallant (Cardiac Rhythm Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $102,199 | 45 |
| 2024 | General | $363,996 | 4,471 |
| 2024 | Research | $270,909 | 148 |
| 2023 | General | $346,895 | 4,307 |
| 2023 | Research | $578,099 | 186 |
| 2022 | General | $131,416 | 1,287 |
| 2022 | Research | $753,714 | 242 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
10,065 general · 621 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.